Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Int J Cancer
    February 2026
  1. PEREZ-LEAL M, Estornut C, Alfaro-Ochoa L, Sanchez-Herrera G, et al
    Cigarette smoke induces expression of senescence markers and pro-inflammatory SASP in oral mucosa: Potential implications for early carcinogenic processes.
    Int J Cancer. 2026;158:752-762.
    >> Share

    December 2025
  2. KRAEMER M, Wirsik NM, Alakus H, Schloesser HA, et al
    Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapy.
    Int J Cancer. 2025;157:2558-2568.
    >> Share

  3. IMLIMTHAN S, Bahrami K, Pehkonen H, Centanni A, et al
    Biological evaluation of a glucose-based boron carrier as a potential agent for boron neutron capture therapy.
    Int J Cancer. 2025;157:2374-2384.
    >> Share

    November 2025
  4. WANG Y, Xi Y, Qiao L, Yu Y, et al
    Ethnic, sex, and age disparities in esophageal cancer and medical costs: A population-based study of 18 million people in China.
    Int J Cancer. 2025 Nov 11. doi: 10.1002/ijc.70236.
    >> Share

    October 2025
  5. JIANG KY, Hu WL, Liu SX, Wang L, et al
    Efficacy of adjuvant immunotherapy and immunochemotherapy in esophageal squamous cell carcinoma: A retrospective cohort study.
    Int J Cancer. 2025 Oct 28. doi: 10.1002/ijc.70214.
    >> Share

  6. SU Q, Feng R, Du S, Zhao H, et al
    Urinary mycotoxins and esophageal cancer risk in China: A case-cohort study.
    Int J Cancer. 2025 Oct 20. doi: 10.1002/ijc.70206.
    >> Share

  7. HAN W, Gao L, Wang X, Li C, et al
    Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.
    Int J Cancer. 2025 Oct 15. doi: 10.1002/ijc.70176.
    >> Share

    September 2025
  8. VERHOEVEN RHA, Kuijper SC, Slingerland M, Wijnhoven B, et al
    Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.
    Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70168.
    >> Share

  9. OSWAL K, Barman S, Kerr AR, Zaman M, et al
    Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India.
    Int J Cancer. 2025 Sep 19. doi: 10.1002/ijc.70160.
    >> Share

  10. VAN DER VEN RGFM, van Erning FN, Westra DD, de Hingh IHJT, et al
    Nationwide trends and the impact of an oncology hospital network on reducing the burden of thyroid cytology procedures.
    Int J Cancer. 2025;157:1120-1129.
    >> Share

  11. AMURE MT, Madathil SA, Laprise C, Rousseau MC, et al
    Oral co-infection with multiple alpha-human papillomavirus and head and neck cancer risk.
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70124.
    >> Share

  12. DENNIS CD, Cohen DJ, Debnath K, Schwartz N, et al
    24R,25(OH)(2)D(3) regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane-associated receptor complexes in ER+ and ER- cells.
    Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70141.
    >> Share

    August 2025
  13. LI ZZ, Wei LY, Cao LM, Wang GR, et al
    Neck management in cT1-2N0 oral squamous cell carcinoma: Act or watchful wait?
    Int J Cancer. 2025;157:614-626.
    >> Share

  14. MA S, Zhang Y, Xie S, Li X, et al
    Balanced diet quality and risk of upper gastrointestinal cancers: Insights from a prospective cohort study in China.
    Int J Cancer. 2025;157:658-671.
    >> Share

  15. NASMAN A, Birgersson M, Nasman T, Jortso E, et al
    Age and tumour presentations differ between HPV type 16 positive and other high-risk HPV type-positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000-2022.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70087.
    >> Share

  16. ZHANG LT, Wu XY, Zhang HY, Li EM, et al
    Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.
    Int J Cancer. 2025 Aug 11. doi: 10.1002/ijc.70080.
    >> Share

    July 2025
  17. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis.
    Int J Cancer. 2025 Jul 30. doi: 10.1002/ijc.70033.
    >> Share

  18. YAN D, Wang L, Huang L, Cheng K, et al
    Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors.
    Int J Cancer. 2025 Jul 19. doi: 10.1002/ijc.70001.
    >> Share

  19. WANG J, Wang L, Wang T, Tang T, et al
    Eye-sparing treatment for sinonasal tumors invading the orbit in the era of personalized therapy.
    Int J Cancer. 2025;157:151-160.
    >> Share

    June 2025
  20. SONG XY, Lin L, Yang Y, Hu HH, et al
    Radiotherapy as an organ-preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy.
    Int J Cancer. 2025 Jun 25. doi: 10.1002/ijc.35515.
    >> Share

  21. MODESTO A, Gibert S, Delmas C, Tougeron D, et al
    Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.
    Int J Cancer. 2025 Jun 20. doi: 10.1002/ijc.70011.
    >> Share

  22. GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al
    Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
    Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491.
    >> Share

  23. CHAN WC, Millwood I, Kartsonaki C, Du H, et al
    Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of 0.5 million Chinese adults.
    Int J Cancer. 2025;156:2094-2106.
    >> Share

    May 2025
  24. LIN H, Ma J, Heng Y, Zhu X, et al
    CD8(+) T cells in patients with hypopharyngeal squamous cell carcinoma are susceptible to radiation-induced damage.
    Int J Cancer. 2025;156:2010-2023.
    >> Share

  25. YAN L, Lin Y, Lin W, Hong J, et al
    Treatment outcomes in nasopharyngeal carcinoma patients with parotid lymph node metastasis: An 11-year experience at a tertiary cancer center.
    Int J Cancer. 2025 May 7. doi: 10.1002/ijc.35470.
    >> Share

    March 2025
  26. LAN K, Liu S, Li S, Sun X, et al
    Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching.
    Int J Cancer. 2025 Mar 29. doi: 10.1002/ijc.35408.
    >> Share


  27. Correction to "Chronotherapy in head and neck cancer: A systematic review and meta-analysis".
    Int J Cancer. 2025 Mar 7. doi: 10.1002/ijc.35396.
    >> Share

    February 2025
  28. HU Y, Lu T, Zhang H, Chen B, et al
    Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study.
    Int J Cancer. 2025 Feb 24. doi: 10.1002/ijc.35382.
    >> Share

  29. WANG H, Fan T, Lu Y, Que L, et al
    Baseline audiometric assessment of newly diagnosed nasopharyngeal carcinoma patients: a multicentre cross-sectional study.
    Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35358.
    >> Share

    January 2025
  30. XIAO Z, Chen W, Du Y, Zeng F, et al
    Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single-arm clinical trial.
    Int J Cancer. 2025 Jan 18. doi: 10.1002/ijc.35340.
    >> Share

  31. POISSONNET V, Uro-Coste E, Chabrillac E, Modesto A, et al
    Malignant salivary gland tumors of the tongue: A multicenter REFCOR study.
    Int J Cancer. 2025;156:310-321.
    >> Share

  32. ZHAO R, Yuan H, Chen S, Xu K, et al
    Impact of accelerated biological aging and genetic variation on esophageal adenocarcinoma: Joint and interaction effect in a prospective cohort.
    Int J Cancer. 2025;156:299-309.
    >> Share

  33. SLOTMAN E, Pape M, van Laarhoven HWM, Pouw RE, et al
    Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.
    Int J Cancer. 2025 Jan 9. doi: 10.1002/ijc.35314.
    >> Share

    December 2024
  34. WANG J, Li B, Zhang Y, Luo X, et al
    Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35261.
    >> Share

  35. JHAWAR SR, Haring C, Pan X, Ma J, et al
    Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35291.
    >> Share

  36. NORONHA V, Patil VM, Menon N, Goud S, et al
    Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer.
    Int J Cancer. 2024;155:2232-2245.
    >> Share

  37. SEWASTJANOW-SILVA M, Kwiatkowski E, Yamashita K, Abdelhakeem A, et al
    Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.
    Int J Cancer. 2024;155:2277-2286.
    >> Share

  38. INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al
    One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study.
    Int J Cancer. 2024;155:1944-1957.
    >> Share

    November 2024
  39. JIN ZY, Liu K, Wallar G, Zhou JY, et al
    Environmental tobacco smoking (ETS) and esophageal cancer: A population-based case-control study in Jiangsu Province, China.
    Int J Cancer. 2024 Nov 18. doi: 10.1002/ijc.35254.
    >> Share

  40. ABUSAMAK M, Abu-Samak AA, Cai W, Al-Waeli H, et al
    Chronotherapy in head and neck cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35234.
    >> Share

  41. RUTKOWSKI TW, Kurczyk A, Drosik-Rutowicz K, Kiprian D, et al
    Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35248.
    >> Share

  42. KARIMI A, Mohebbi E, Mckay-Chopin S, Hadji M, et al
    Association of opium use and tobacco smoking with alpha-, beta-, and gamma-human papillomavirus oral infection.
    Int J Cancer. 2024;155:1544-1548.
    >> Share

  43. SCHEI-ANDERSEN AJ, Hendricks LAJ, van der Post RS, Mensenkamp AR, et al
    Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.
    Int J Cancer. 2024;155:1567-1576.
    >> Share

    October 2024

  44. RETRACTION: A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer.
    Int J Cancer. 2024 Oct 22. doi: 10.1002/ijc.35230.
    >> Share

  45. HSU WL, Tao J, Fu S, Yu KJ, et al
    Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.
    Int J Cancer. 2024;155:1400-1408.
    >> Share

  46. SHEN Y, You Z, Li L, Tang X, et al
    The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis.
    Int J Cancer. 2024;155:1290-1302.
    >> Share

  47. YAN X, Zeng H, Li H, Cao M, et al
    The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population-based cohort study.
    Int J Cancer. 2024;155:1203-1211.
    >> Share

    September 2024
  48. WANG W, Ye L, Li H, Chen W, et al
    A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions.
    Int J Cancer. 2024 Sep 14. doi: 10.1002/ijc.35153.
    >> Share

  49. PIRES C, Marques IJ, Saramago A, Moura MM, et al
    Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways.
    Int J Cancer. 2024 Sep 9. doi: 10.1002/ijc.35159.
    >> Share

  50. IWAKI S, Kawakita D, Nagao T, Tada Y, et al
    Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan.
    Int J Cancer. 2024;155:871-882.
    >> Share

    August 2024
  51. JANKE F, Stritzke F, Dvornikovich K, Franke H, et al
    Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
    Int J Cancer. 2024 Aug 30. doi: 10.1002/ijc.35152.
    >> Share

  52. SHI X, Lu M, Li X, Li J, et al
    The transcriptional landscape and clinico-biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma.
    Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35147.
    >> Share

  53. HUANG H, Zhao Y, Deng Y, Zhan Z, et al
    Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.
    Int J Cancer. 2024 Aug 26. doi: 10.1002/ijc.35139.
    >> Share

    July 2024
  54. WENG Z, Mai Z, Yuan J, Liu Q, et al
    Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy.
    Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35118.
    >> Share

  55. LAURITZEN BB, Gronlund MW, Jakobsen KK, Justesen MM, et al
    Epidemiological trends and survival of oropharyngeal cancer in a high HPV-prevalent area: A Danish population-based study from 2000 to 2020.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35099.
    >> Share

  56. WANG R, Chen XZ
    Comment on "Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study".
    Int J Cancer. 2024;155:184-185.
    >> Share

    June 2024
  57. MA L, Wang TM, He YQ, Liao Y, et al
    Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2024 Jun 18. doi: 10.1002/ijc.35061.
    >> Share

  58. SUN X, Lin X, Yao J, Tian T, et al
    Potential causal links of long-term exposure to PM(2.5) and its chemical components with the risk of nasopharyngeal carcinoma recurrence: A 10-year cohort study in South China.
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35047.
    >> Share

    May 2024
  59. GUO D, Jin J, Li D, He Y, et al
    Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan.
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35003.
    >> Share

  60. HUI Z, Wang B, Liu Z, Wei J, et al
    TGFbeta-induced EN1 promotes tumor budding of adenoid cystic carcinoma in patient-derived organoid model.
    Int J Cancer. 2024;154:1814-1827.
    >> Share

  61. KITAHARA CM, Surcel HM, Falk R, Pfeiffer RM, et al
    Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort.
    Int J Cancer. 2024 May 2. doi: 10.1002/ijc.34974.
    >> Share

  62. FANG F, Ritz B, Rao J, Zhu Y, et al
    Association between ambient exposure to PM(2.5) and upper aerodigestive tract cancer in Los Angeles.
    Int J Cancer. 2024;154:1579-1586.
    >> Share

    April 2024
  63. VASILIADOU I, Grose D, Wilson C, Thapa A, et al
    The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963.
    >> Share

  64. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    >> Share

  65. NAKAGAWA T, Santos J, Nasamran CA, Sen P, et al
    Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA-sequencing.
    Int J Cancer. 2024;154:1492-1503.
    >> Share

  66. DI W, Yu J, Zong D, Ge Y, et al
    Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
    Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
    >> Share

  67. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    >> Share

  68. LEE JH, Ming Z, Cheung VKY, Pedersen B, et al
    Ex vivo tissue modelling informs drug selection for rare cancers.
    Int J Cancer. 2024;154:1158-1163.
    >> Share

    March 2024
  69. CHARTERS E, Cheng K, Dunn M, Heng C, et al
    Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
    Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
    >> Share

  70. DOHERTY N, Cardwell C, Murchie P, Hill C, et al
    Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study.
    Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34937.
    >> Share

  71. MADRIGAL JM, Troisi R, Surcel HM, Ohman H, et al
    Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Int J Cancer. 2024;154:979-991.
    >> Share

  72. LU Y, Clifford GM, Fairley CK, Grulich AE, et al
    Human papillomavirus and p16(INK4a) in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2024;154:830-841.
    >> Share

    February 2024
  73. RINALDI S, Dossus L, Keski-Rahkonen P, Kiss A, et al
    Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
    Int J Cancer. 2024 Feb 15. doi: 10.1002/ijc.34872.
    >> Share

  74. SEYYEDSALEHI MS, Boffetta P
    Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34881.
    >> Share

  75. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34861.
    >> Share

    January 2024
  76. KAIMILA B, Yano Y, Mulima G, Chen Y, et al
    Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34829.
    >> Share

    November 2023
  77. STUART CM, Meguid RA, Bronsert MR, Rodriguez Franco S, et al
    The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.
    Int J Cancer. 2023 Nov 28. doi: 10.1002/ijc.34805.
    >> Share


  78. Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
    Int J Cancer. 2023 Nov 19. doi: 10.1002/ijc.34789.
    >> Share

  79. RANGEL-POZZO A, Dos Santos FF, Dettori T, Giulietti M, et al
    Three-dimensional nuclear architecture distinguishes thyroid cancer histotypes.
    Int J Cancer. 2023;153:1842-1853.
    >> Share

    October 2023
  80. DOCHI H, Kondo S, Komura S, Moriyama-Kita M, et al
    Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34777.
    >> Share

    September 2023
  81. RAN X, Zeng H, Zheng R, Sun K, et al
    Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population-based study.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34730.
    >> Share

  82. SCOBIOALA S, Parfitt R, Matulat P, Byrne J, et al
    The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34732.
    >> Share

  83. KUSTERS JMA, Diergaarde B, Ness A, Schim van der Loeff MF, et al
    Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34710.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016